Pain Rehabilitation Virtual Reality (PRVR): Innovations to Enhance Mobility in the Presence of Pain
PRVR
2 other identifiers
interventional
34
1 country
2
Brief Summary
The proposed research is a single arm feasibility trial of pain rehabilitation virtual reality (PRVR) aimed at measuring feasibility, acceptability and utility of VR as well as changes in physical function and fear for adolescents with chronic musculoskeletal pain. The intervention includes standard physiotherapy treatment including functional goal setting and progressive exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Mar 2022
Typical duration for not_applicable chronic-pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2020
CompletedFirst Posted
Study publicly available on registry
November 19, 2020
CompletedStudy Start
First participant enrolled
March 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 7, 2024
CompletedResults Posted
Study results publicly available
November 14, 2025
CompletedNovember 14, 2025
October 1, 2025
2.7 years
November 13, 2020
August 25, 2025
October 30, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
VR Duration of Use Per Week
This outcome is to assess Feasibility, Acceptability, and Utility of VR.
Baseline to end of treatment across 6-8 weeks, on average
Participant Rated Ease of Use
This outcome is to assess Feasibility, Acceptability, and Utility of VR.
End of treatment at 6-8 weeks, on average
Participant Rated Enjoyment
This outcome is to assess Feasibility, Acceptability, and Utility of VR.
End of treatment at 6-8 weeks, on average
Secondary Outcomes (3)
Pain-related Fear and Avoidance
Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment
Physical Function: Lower Extremity
Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment
Physical Function: Upper Extremity
Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment
Study Arms (2)
Pain Rehabilitation Virtual Reality (PRVR)
EXPERIMENTALParticipants will complete VR in PT to engage participants in a series of immersive games customized to align with individual PT needs delivered over \~6-12 weeks or until clinician believes the patient is done with treatment. Patients in the PRVR arm will be given a structured HEP to practice prescribed exercises at home with integrated VR activities. PRVR participants will be allocated a VR headset for use in PT sessions and with HEP. VR will supplement treatment and be used in session (either in-person or telehealth) and at home as part of their prescribed treatment homework.
Standard Physiotherapy Rehabilitation (SPR)
ACTIVE COMPARATORSessions are individually-tailored and based on the Guide to Physical Therapy Practice 3.0 consisting of 1) therapeutic exercise, 2) balance and proprioception, 3) strength training, and 4) use of modalities (e.g., heat/cold pack). Patients will be given a structured Home Exercise Program (HEP) with prescribed exercises for home. SPR participants will be allocated a VR headset for recreational use.
Interventions
Participants will receive approximately 8, 1-hour physiotherapy sessions delivered over the course of 6-12 weeks. Adequate dose: 75% (6 of 8 sessions).
Participants allocated to either intervention arm will receive 8, 1-hour physiotherapy sessions delivered over the course of 6-8 weeks. Adequate dose: 75% (6 of 8 sessions).
Eligibility Criteria
You may qualify if:
- to 17 years old
- Musculoskeletal pain (e.g. localized \[back, limb\], diffuse) not due to acute trauma (e.g. active sprain or fracture)
- English Language Proficiency
You may not qualify if:
- Significant cognitive impairment (e.g., brain injury)
- Significant medical or psychiatric problem that would interfere (e.g. psychosis, suicidality)
- Presents with a condition that interferes with virtual reality usage (e.g., history of seizure, facial injury precluding safe placement of headset, visual impairment, significant hearing impairment impact ability to follow audio instructions).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Pediatric Pain Management Clinic - Stanford Children's Health
Menlo Park, California, 94025, United States
California Rehabilitation and Sports Therapy
Palo Alto, California, 94306, United States
Related Publications (1)
Simons LE, Hess CW, Choate ES, Van Orden AR, Tremblay-McGaw AG, Menendez M, Boothroyd DB, Parvathinathan G, Griffin A, Caruso TJ, Stinson J, Weisman A, Liu T, Koeppen K. Virtual Reality-Augmented Physiotherapy for Chronic Pain in Youth: Protocol for a Randomized Controlled Trial Enhanced With a Single-Case Experimental Design. JMIR Res Protoc. 2022 Dec 12;11(12):e40705. doi: 10.2196/40705.
PMID: 36508251DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Laura E Simons
- Organization
- Stanford University School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Simons, PhD
Stanford School of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 13, 2020
First Posted
November 19, 2020
Study Start
March 10, 2022
Primary Completion
December 7, 2024
Study Completion
December 7, 2024
Last Updated
November 14, 2025
Results First Posted
November 14, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Beginning 3 months and ending 5 years following article publication.
- Access Criteria
- Proposals should be directed to Dr. Laura Simons at lesimons@stanford.edu. To gain access, data requestors will need to sign a data access agreement with Stanford University.
Individual participant data (text, tables, figures, appendices) that underlie the results reported in an article related to this trial will, after de-identification, be shared with researchers who provide a methodologically sound proposal.